English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduDavid Winter, MD, at Baylor Scott & White Health, answers the most common patient questions and reacts to the latest medical research. Are COVID cases starting to go down? (SOT@ :14, TRT :49) How reliable are at-home COVID tests? Can…
Tag: Paxlovid
Study Shows Paxlovid Can Safely Be Used to Reduce Risk of Severe COVID in People Who Are Pregnant
Findings from a Johns Hopkins Medicine research study published today in JAMA Network Open provide strong evidence that people who are pregnant and have been infected with SARS-CoV-2 (the virus that causes COVID-19) can safely take the antiviral drug Paxlovid to reduce the possibility of severe disease.
Some Pre-existing Mutant Strains of the Virus Causing COVID-19 May Resist Paxlovid
Doctors should reserve Paxlovid for the highest risk patients because if Paxlovid is widely used, it mostly will destroy the variants it can treat, says a Rutgers researcher.
COVID-19 Rebound after Taking Paxlovid Likely Due to Insufficient Drug Exposure
COVID-19 rebound following Paxlovid treatment likely due to insufficient drug exposure, UC San Diego researchers find after showing rebound patient did not show drug resistance or impaired immunity.
Study finds few COVID-19 patients get rebound symptoms after Paxlovid treatment
Mayo Clinic researchers studied the outcomes of 483 high-risk patients treated for COVID-19 with a five-day oral regimen of nirmatrelvir and ritonavir, together marketed as Paxlovid. Only a handful developed COVID-19 rebound symptoms, and the researchers say more studies are needed to determine why.